Docemaps 20 Mg Injection

Description

Docemaps 20mg Injection is a medication containing Doxercalciferol as its active ingredient. Doxercalciferol is a vitamin D analog that works by helping the body absorb calcium and phosphate from the digestive tract. These minerals are crucial for maintaining healthy bones and for the proper functioning of parathyroid glands. Docemaps 20mg Injection is primarily indicated for the prevention and treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD), particularly those on dialysis. Secondary hyperparathyroidism is a condition where the parathyroid glands become overactive due to low levels of calcium and vitamin D, and high levels of phosphate, often seen in individuals with impaired kidney function. By normalizing parathyroid hormone (PTH) levels, Docemaps helps to improve calcium and phosphate balance, thereby reducing the risk of bone disease and other complications associated with CKD. The typical dosage and administration will be determined by a healthcare professional based on individual patient needs and laboratory results. Common side effects may include hypercalcemia (high calcium levels), hyperphosphatemia (high phosphate levels), nausea, vomiting, and headache. It is essential to store Docemaps 20mg Injection at room temperature, protected from light and moisture, and out of reach of children. Always use this medication as prescribed by your doctor.